Revenue | ₹15.30Cr |
Net Profits | ₹-6.11Cr |
Net Profit Margins | -39.93% |
Oxygenta Pharmaceutical Ltd’s revenue jumped 21.04% since last year same period to ₹15.30Cr in the Q1 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -69.1% fall in its revenue since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit fell -349.26% since last year same period to ₹-6.11Cr in the Q1 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -184.19% fall in its net profits since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit margin fell -271.16% since last year same period to -39.93% in the Q1 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -819.8% fall in its net profit margins since last 3-months.
The revenue for Oxygenta Pharmaceutical Ltd in the Q1 results 2025 was ₹15.30Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q1 results 2025 was ₹-6.11Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q1 results 2025 was -39.93%.
The revenue for Oxygenta Pharmaceutical Ltd in the Q1 results 2024 was ₹12.64Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q1 results 2024 was ₹-1.36Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q1 results 2024 was -10.76%.